Examination of Factors Affecting Adverse Reactions and Dosage Reduction in UGT1A1 Genotyped Patients: A Retrospective Survey of Irinotecan
Released on J-STAGE: February 01, 2012 |
Volume 132
Issue 2
Pages 231-236
Keinosuke Okazaki, Toru Watanabe, Isao Saito, Jun-Ichiro Murayama
Views: 547